Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Finasteride gel and tablet both have similar moderate effects in treating male hair loss.

Micrografts and minigrafts effectively treat male hair loss with natural-looking results.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Androgenetic alopecia may increase the severity of COVID-19.

Early detection and trichoscopy are key for treating hair loss effectively.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Men with early baldness often have low vitamin D levels.

PRP improves hair growth in AGA, but higher concentrations aren't significantly better than lower ones.

Men with androgenetic alopecia (hair loss) are more likely to have fatty liver disease than those without hair loss.

Androgenetic alopecia may be linked to severe COVID-19.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Hairline recession makes Asian males look older, especially in mid-young age; proper hairline position can help them look younger.

Using lasers to deliver minoxidil can potentially improve its effectiveness in treating male pattern hair loss.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss linked to prostate enlargement; stress and family history important factors.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

Androgenetic alopecia is a common form of hair loss in both men and women.

Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.

Men with early-onset baldness may have a higher risk of heart disease.

Family history affects hair loss severity and onset more in men than women.

Androgenetic alopecia is more common in males, can be influenced by lifestyle, and may be linked to other skin issues.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.

Crescina treatment improves hair resistance and reduces hair loss.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Early-onset hair loss is linked to Parkinson's disease and decreased fertility.